"Blind mule" is a term meaning individuals who are used to transport people or illegal substances across international ...

U.S. President Donald Trump directed his health department on Tuesday to work with Congress on revamping a law that allows ...

Proposed tariffs on pharmaceutical imports could destabilize U.S. generic drug supply, warns Dr. Scott Gottlieb.

The U.S. Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal ...

HHS Secretary Robert F. Kennedy Jr.’s sweeping layoffs across federal health agencies is disrupting the work of drug, medical device, and food reviewers, forcing employees to pick up additional duties ...

A new cancer drug called trastuzumab deruxtecan, also known as Enhertu, has just been approved in the UK. This drug is ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

Several French prisons were attacked overnight in response to government efforts to clamp down on drug trafficking, senior ...

If you have been advised by a primary care provider to take prescription Ozempic, you should know that counterfeit ...

J&J’s comments and guidance update come as the company kicks off 2025’s first-quarter earnings round for large drugmakers.

To combat long-overlooked fungal pathogens, researchers and regulators must embrace innovative science and policy.

Wyatt McDonnell of Infinimmune shares insight on human-first models and what the FDA's policy shift means for biotech R&D.